CRISPR-Cas-Based Genome Editing for Treating Human Diseases - Part B: Volume 210
★★★★★
★★★★★
English
CRISPR-Cas-Based Genome Editing for Treating Human Diseases, Part B represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems have been proven to be a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. Chapters in this release include Current approaches in CRISPR Cas systems for metabolic disorders, Recent progress in CRISPR Cas systems for CRISPR for retinal diseases, Recent progress in CRISPR Cas systems for cataract and blindness, Advances in CRISPR Cas systems for muscular dystrophy, Recent development in CRISPR Cas systems for cardiac disease, Current approaches in CRISPR Cas systems for diabetes, and much more. Additional sections cover Advances in CRISPR Cas systems for liver disease, Advances in CRISPR Cas systems for lung disease, Advances in CRISPR Cas systems for kidney diseases, Current progress in CRISPR Cas systems for rare disease, Advances in CRISPR Cas systems for heredity disease, Recent progress in CRISPR Cas systems for neurological disorders, and CRISPR challenges in clinical developments.
See more
Current price
€126.34
Original price
€132.99
Save 5%
Will deliver when available. Publication date 01 Jan 2025
Product Details
Dimensions: 152 x 229mm
Publication Date: 01 Jan 2025
Publisher: Elsevier Science Publishing Co Inc
Publication City/Country: United States
Language: English
ISBN13: 9780443224201
About
Dr Vijai Singh is a Professor and Dean (Research & Innovation) at School of Sciences Indrashil University Rajpur Mehsana Gujarat India. He was an Associate Professor in the Department of Biosciences School of Sciences Indrashil University Rajpur Mehsana Gujarat India. Prior this this he was an Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research Gandhinagar India and also an Assistant Professor in the Department of Biotechnology at the Invertis University Bareilly India. Prior to that he was a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology Paris France and School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology Ulsan South Korea. He received his Ph.D. in Biotechnology from the National Bureau of Fish Genetic Resources Uttar Pradesh Technical University Lucknow India with a research focus on the development of molecular and immunoassays for diagnosis of Aeromonas hydrophila. His research interests are focused on building novel biosynthetic pathways for production of medically and industrially important biomolecules. Additionally his laboratory is working on CRISPR-Cas9 tools for genome editing. He has more than 11 years of research and teaching experience in synthetic biology metabolic engineering bioinformatics microbiology and industrial microbiology. He has published 100 articles 70 chapters 15 books and 3 patents. He serves as an associate editor editorial board member and reviewer of several peer-reviewed journals. He is also a member of the Board of Study and Academic Council of Indrashil University and is the Member Secretary of the Institutional Biosafety Committee (IBSC) at the same University.